Sign In
Buy ATRA
$9.63
-0.270 (-2.73%)
At Close: Jun 03, 2026
Atara Biotherapeutics Prices 12.6M Share Public Offering @$11.32/Share
09:44am, Wednesday, 27'th May 2020Atara Biotherapeutics Announces Pricing of $175.5 Million Public Offering
05:16am, Wednesday, 27'th May 2020
Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with severe diseases i
Atara Biotherapeutics Announces Pricing of $175.5 Million Public Offering
12:00am, Wednesday, 27'th May 2020
Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transforma
Atara Biotherapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants; No Terms Disclosed
08:09pm, Tuesday, 26'th May 2020Atara Biotherapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants
08:05pm, Tuesday, 26'th May 2020
Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with severe diseases i
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop treatments for patients with severe diseases, including sol
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop treatment
Atara Jumps After Data Released On Multiple Sclerosis Study
12:00am, Saturday, 23'rd May 2020The Daily Biotech Pulse: FDA Nod For Aquestive, Tetraphase M&A Plot Thickens, Amarin's Vascepa In COVID Fray
12:00am, Friday, 22'nd May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 21)
ADC Therapeutics SA (NYSE:...
